REGN - Regeneron Pharmaceuticals, Inc.
IEX Last Trade
1184.19
5.260 0.444%
Share volume: 405,349
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1,178.93
5.26
0.45%
Summary score
57%
Profitability
68%
Dept financing
7%
Liquidity
72%
Performance
54%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.13%
Return on assets
5.53%
Return on sales
40.49%
Return on invested capital
18.48%
Total debt ratio
25.78%
Debt ratio change over timeo
1.18%
Current Ratio
4.64%
Quick Ratio
3.93%
Cash Position Ratio
2.18%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
4.07%
Return on assets
3.03%
Return on sales
30.26%
Return on invested capital
9.55%
Total debt ratio
21.84%
Debt ratio change over timeo
1.43%
Current Ratio
5.39%
Quick Ratio
4.63%
Cash Position Ratio
2.91%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
5.08%
Return on assets
3.07%
Return on sales
31.24%
Return on invested capital
10.61%
Total debt ratio
21.84%
Debt ratio change over time
1.06%
Current Ratio
5.44%
Quick Ratio
4.62%
Cash Position Ratio
2.8%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-48.63%
Return on assets
-61.95%
Return on sales
221.82%
Return on invested capital
23.78%
Total debt ratio
118.29%
Debt ratio change over time
1.18%
Current Ratio
41.19%
Quick Ratio
34.8%
Cash Position Ratio
19.7%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | REGN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 7.13% | 15.05% | 35.64% | 4.42% |
| Return on assets | 5.53% | 2.88% | 3.13% | 5.74% |
| Return on sales | 40.49% | 29.62% | 32.25% | 42.85% |
| Return on invested capital | 18.48% | 2.57% | 5.37% | 28.91% |
| Profitability | 69% | 43% | 62% | 78% |
| Total debt ratio | 25.78% | 90.48% | 91% | 24.37% |
| Debt ratio change over time | 1.18% | 326.95% | -8.44% | 0.07% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 5.39% | 0.92% | 1.98% | 3.52% |
| Quick Ratio | 4.63% | 0.81% | 1.56% | 3.3% |
| Cash Position Ratio | 2.91% | 0.39% | 1.05% | 2.7% |
| Liquididy | 66% | 12% | 27% | 73% |
| Short-term ratios | REGN | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 4.07% | 13.14% | 10.88% | -1.65% |
| Return on assets | 3.03% | 2.1% | 1.54% | 4.74% |
| Return on sales | 30.26% | 21.74% | 18.43% | 40.61% |
| Return on invested capital | 9.55% | 1.95% | 2.74% | 4.62% |
| Profitability | 67% | 55% | 47% | 62% |
| Total debt ratio | 21.84% | 92.68% | 93.24% | 23.93% |
| Debt ratio change over time | 1.43% | 51.04% | -101.54% | -0.22% |
| Dept financing | 7% | 50% | 25% | 6% |
| Current Ratio | 5.39% | 0.92% | 1.98% | 3.52% |
| Quick Ratio | 4.63% | 0.81% | 1.56% | 3.3% |
| Cash Position Ratio | 2.91% | 0.39% | 1.05% | 2.7% |
| Liquididy | 75% | 12% | 27% | 57% |